Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

4-Traders Homepage  >  Equities  >  Nasdaq  >  Ariad Pharmaceuticals, Inc.    ARIA

 SummaryQuotesNewsCalendarCompanyFinancialsConsensusRevisions 
Financials ($)
More Financials
Company
ARIAD Pharmaceuticals, Inc. operates as an oncology company, which engages in the discovery, development, and commercialization of small-molecule drugs for the treatment of cancer.Its products include Iclusig and Caregivers.The company was founded by Harvey J. Berger in April 1991 and is... 
More about the company
Latest news on ARIAD PHARMACEUTICALS, INC
02/18 ARIAD PHARMACEUTICALS : Medinol Announces Appointment Of Harvey J. Berger, M.D.,..
02/18 TAKEDA PHARMACEUTICAL : Japans Takeda acquires US cancer drug manufacturer ARIAD..
02/16 ARIAD PHARMACEUTICALS INC : Entry into a Material Definitive Agreement, Completi..
02/16 ARIAD PHARMACEUTICALS : Announces Submission of Marketing Authorization Applicat..
02/06 ARIAD PHARMACEUTICALS INC : Other Events, Financial Statements and Exhibits (for..
02/06 LAWSUIT FOR INVESTORS AGAINST ACQUIS : ARIA) Filed
02/06 ARIAD PHARMACEUTICALS : Announces Submission of Marketing Authorization Applicat..
02/03 ARIAD PHARMACEUTICALS : Enters into Definitive Agreement to Be Acquired by Taked..
02/03 ARIAD PHARMACEUTICALS : Takeda to Acquire ARIAD Pharmaceuticals, Inc.
01/26 TAKEDA PHARMACEUTICAL : Commences Cash Tender Offer for All Outstanding Shares o..
More news
Sector news : Bio Therapeutic Drugs
03/18DJAMGEN : Repatha Study Shows Reduced Risk of Heart Attack, Stroke -- 3rd Update
03/17DJAMGEN : Repatha Study Shows Reduced Risk of Heart Attack, Stroke -- 2nd Update
03/17DJAMGEN : Money-Back Guarantee
03/17DJAmgen's Repatha Study Shows Reduced Risk of Heart Attack, Stroke -- Update
03/17DJAmgen's Repatha Study Shows Reduced Risk of Heart Attack, Stroke
More sector news : Bio Therapeutic Drugs
Latest Tweets
03/14Get the latest news and updates for $WINT $ARIA $VTTI $SPIL $FRC automaticall.. 
03/07Roche Looks Ready To Rule Another Cancer Niche  
03/06Biotech Forum Daily Digest: Biotech Closes Above Resistance Levels. Icahn Get.. 
03/06Biotech Forum Daily Digest: Biotech Closes Above Resistance Levels. Icahn Get.. 
03/06Biotech Bonanza: Breaking New Ground And More To Go  
More tweets
Qtime:52
News from SeekingAlpha
03/07 Roche Looks Ready To Rule Another Cancer Niche
03/06 BIOTECH FORUM DAILY DIGEST : Biotech Closes Above Resistance Levels. Icahn Getti..
03/06 BIOTECH BONANZA : Breaking New Ground And More To Go
02/23 SEEKING ALPHA INTERVIEWS : Bret Jensen On Promising Drugs And Acquisition Target..
02/16 Icahn Boosts Herbalife Bet While Advising Trump
Advertisement
Technical analysis trends ARIAD PHARMACEUTI...
Short TermMid-TermLong Term
TrendsBearishBearishBearish
Technical analysis
Income Statement Evolution
More Financials
Consensus 
Mean consensus
Number of Analysts
Average target price -
Spread / Average Target
Consensus details
EPS Revisions
More Estimates Revisions
Managers
NameTitle
Christophe M. Bianchi President
Manmeet Singh Soni Chief Financial Officer, Treasurer & Executive VP
Timothy P. Clackson Chief Scientific Officer
Nicholas Ventresca Chief Information Officer & Senior Vice President
Liza Heapes Senior Manager-Corporate Communications
More about the company
Sector and Competitors
1st jan.Capitalization (M$)
ARIAD PHARMACEUTICALS,..0.00%0
AMGEN, INC.13.36%122 060
CELGENE CORPORATION6.59%95 986
GILEAD SCIENCES, INC.-5.73%88 240
REGENERON PHARMACEUTIC..1.61%39 568
ACTELION LTD24.44%29 804
More Results